Pfizer files US vaccine application for adolescents

Photo of author

By admin

The American company Pfizer and its German partner BioNTech, which developed vaccines against the Comirnaty coronavirus, have filed an application with the US Food and Drug Administration (FDA) to obtain an emergency drug license for adolescents aged 12 to 15 years. This was announced on Friday, April 9, in the official account of the American company in Twitter

“Today, with BioNTech, we sent a request to the US FDA to expand the use of our COVID-19 vaccine in emergencies among adolescents aged 12 to 15,” the statement said.

The company stressed that in the near future it is planned to submit applications to obtain permission for the use of the vaccine, and to other regulatory bodies.

On April 7, it became known that in the US state of Michigan, about 250 people who received two doses of the COVID-19 vaccine fell ill with the coronavirus. Of the 1.7 million people who were vaccinated, 246 people tested positive within 14 days after receiving the vaccine.

There have also been several reported deaths following vaccination in various countries, including Austria, Australia and Lithuania, and links to Pfizer vaccinations are being established.

On January 15, a US resident posted a video on his Facebook page of his mother, who developed adverse side effects after being vaccinated with Pfizer. When viewing, you can see that the woman is trembling. On the same day, Chinese health professionals called for an end to the use of the Pfizer coronavirus vaccine among the elderly. The appeal was prompted by doubts about the safety of the vaccine due to the deaths of 23 elderly Norwegians who received the vaccine.